New test better predicts which babies will develop type 1 diabetes

A new approach to predicting which babies will develop type 1 diabetes moves a step closer to routine testing for newborns which could avoid life-threatening complications.

Scientists at seven international sites have followed 7,798 children at high risk of developing type 1 diabetes from birth, over nine years, in The Environmental Determinants of Diabetes in the Young (TEDDY) Study. The TEDDY Study is a large international study funded primarily by the US National Institutes of Health and U.S. Centers for Disease Control, as well as by the charity JDRF.

In research published in Nature Medicine, scientists at the University of Exeter and the Pacific Northwest Research Institute in Seattle used the TEDDY data to develop a method of combining multiple factors that could influence whether a child is likely to develop type 1 diabetes. The combined risk score approach incorporates genetics, clinical factors such as family history of diabetes, and their count of islet autoantibodies — biomarkers known to be implicated in type 1 diabetes. …

It’s a given that receiving the MMR vaccine will not among the factors in this model, because every doctor  knows vaccines don’t cause autoimmune reactions.   They simply fine-tune the immune system with a sledge hammer.   What could go wrong?

Study: MMR Vaccine Linked to Type 1 Diabetes

Juvenile Diabetes and Vaccination: New Evidence for a Connection

Type 1 Diabetes Up 30% Since 2017, According to CDC

Tinker Toy Medicine and Vaccine Induced Autoimmunity

African Americans are Disproportionately Affected by Vaccines

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.